Targeted oncology KinaSense focuses on testing tyrosine kinase inhibitors in pre-clinical drug discovery and clinical applications, presenting an opportunity to engage with oncology researchers, biopharma partners, and contract research organizations seeking precision medicine tools.

Live-cell sensors Their live-cell tyrosine kinase activity sensors in cancer patient biopsies suggest a potential use case for diagnostic and companion diagnostic collaborations, as well as lab services for biomarker validation and patient stratification.

Early-stage traction With a small team and revenue in the low millions or less, KinaSense may be seeking strategic collaborations, pilot projects, and grant-funded programs to scale technology validation and accelerate customer onboarding.

Biotech niche Operating in Lafayette, Indiana with a biotech research focus, there is potential for regional partnerships, access to local academic collaborations, and government or state incentives to support R&D and pilot deployments.

Tech stack fit Their tech stack highlights web and data presentation tools; sales opportunities could include instrumented lab integration, data analytics platforms, and seamless integration with existing research workflows to lower adoption barriers.